Judith M. Matthews

Judith M. Matthews, listed as finance chief, appears in our data through filings on Iterum Therapeutics plc shares, published by SEC (Form 4). In total, 12 filings cover trades dated from 30 May 2018 to 11 March 2023.

Market trades split into 1 purchase (€45k) and 4 sales (€161k). Taken together, the sales exceed the purchases by €117k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 4 share grants.

Most recently, on 14 March 2023, the filings show a share grant worth €2,615 in Iterum Therapeutics plc. The last purchase on record was published on 30 May 2018, which is 3,068 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.